What: Recently in the US a study was conducted on 18 patients suffering from rectal cancer. the aim of the study was to check the efficacy of the drug aimed to cure cancer
Why: In all patients, rectal cancer was locally advanced. This means the tumours had spread within the rectum and in some cases, to the lymph nodes, but not to other organs
Results: At the end of the trial, cancer was checked for and remained undetected through physical exam, endoscopy, positron emission tomography or PET scans or MRI scan.
What next: The results have made scientists believe that the Dostarlimab works by "unmasking" cancer cells, which in turn helps the immune system identify and destroy them. Notably, this is one of the major development for the scientific community which would help million of patients suffering from cancer